Tag: Corrective and preventive actions GMP

How MHRA Ensures GMP Compliance in the UK Pharmaceutical Manufacturing Sector

February 14, 2025 digi

How MHRA Ensures GMP Compliance in the UK Pharmaceutical Manufacturing Sector Understanding the Role of MHRA in GMP Compliance for UK Pharmaceutical Manufacturers Introduction to MHRA and GMP Compliance The Medicines and Healthcare products Regulatory Agency (MHRA) is the primary regulatory authority in the United Kingdom responsible for ensuring compliance with Good Manufacturing Practices (GMP)…

GMP in Europe (EMA, MHRA)

Best Practices for GMP Compliance in High-Risk Drug Manufacturing in Emerging Markets

February 13, 2025 digi

Best Practices for GMP Compliance in High-Risk Drug Manufacturing in Emerging Markets GMP Compliance Strategies for High-Risk Drug Manufacturing in Emerging Markets Introduction to High-Risk Drug Manufacturing and GMP Compliance Manufacturing high-risk drugs, such as sterile injectables, biologics, and controlled substances, requires strict adherence to Good Manufacturing Practices (GMP). These products are more susceptible to…

GMP in Emerging Markets (GCC, Latin America, Africa)

How to Prepare for a Schedule M Revised GMP Inspection in India

February 13, 2025 digi

How to Prepare for a Schedule M Revised GMP Inspection in India Step-by-Step Preparation for Schedule M Revised GMP Inspections Introduction to Schedule M Revised GMP Inspections The revised Schedule M under the Drugs and Cosmetics Rules, 1945, has introduced stricter Good Manufacturing Practices (GMP) guidelines for pharmaceutical manufacturers in India. Regulatory inspections are conducted…

GMP in India

How to Use Risk-Based Approaches for GMP Compliance in the EU

February 13, 2025 digi

How to Use Risk-Based Approaches for GMP Compliance in the EU Practical Tips for Implementing Risk-Based Approaches to GMP Compliance in the EU Introduction to Risk-Based Approaches in GMP Compliance Maintaining Good Manufacturing Practices (GMP) compliance is a cornerstone of pharmaceutical manufacturing in the European Union (EU). The European Medicines Agency (EMA) encourages manufacturers to…

GMP in Europe (EMA, MHRA)

How to Implement CAPA for GMP Compliance in Emerging Markets

February 13, 2025 digi

How to Implement CAPA for GMP Compliance in Emerging Markets A Step-by-Step Guide to Implementing CAPA for GMP Compliance in Emerging Markets Introduction to CAPA and GMP Compliance Corrective and Preventive Action (CAPA) is an essential component of Good Manufacturing Practices (GMP) in pharmaceutical manufacturing. CAPA ensures that non-conformities are addressed effectively, and measures are…

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India

February 13, 2025 digi

How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India Expert Insights on Testing and Releasing Pharmaceutical Products Under Schedule M Revised Introduction to Testing and Release Requirements Under Schedule M Revised Pharmaceutical manufacturing demands rigorous quality checks to ensure that products meet safety, efficacy, and compliance standards. The Schedule M…

GMP in India

Best Tools for Monitoring GMP Compliance in European Pharmaceutical Facilities

February 13, 2025 digi

Best Tools for Monitoring GMP Compliance in European Pharmaceutical Facilities Top Tools to Ensure GMP Compliance in European Pharma Facilities Introduction to GMP Monitoring Tools Compliance with Good Manufacturing Practices (GMP) is essential for ensuring the safety, efficacy, and quality of pharmaceutical products in Europe. The European Medicines Agency (EMA) mandates strict adherence to GMP…

GMP in Europe (EMA, MHRA)

The Impact of GMP on Pharmaceutical Product Stability in Emerging Markets

February 13, 2025 digi

The Impact of GMP on Pharmaceutical Product Stability in Emerging Markets Exploring the Role of GMP in Ensuring Pharmaceutical Product Stability in Emerging Markets Introduction to GMP and Product Stability Ensuring pharmaceutical product stability is a critical aspect of drug manufacturing, directly affecting product quality, safety, and efficacy throughout its shelf life. In emerging markets…

GMP in Emerging Markets (GCC, Latin America, Africa)

The Importance of Validating Processes and Procedures for Schedule M Revised Compliance

February 12, 2025 digi

The Importance of Validating Processes and Procedures for Schedule M Revised Compliance Why Validating Processes and Procedures is Crucial for Schedule M Revised Compliance Introduction to Process Validation and Schedule M Revised In pharmaceutical manufacturing, the validation of processes and procedures is critical for ensuring consistent product quality and compliance with regulatory standards. The revised…

GMP in India

How to Achieve Compliance with GMP in Europe for New Drug Introductions

February 12, 2025 digi

How to Achieve Compliance with GMP in Europe for New Drug Introductions Step-by-Step Guide to Ensuring GMP Compliance for New Drug Introductions in Europe Introduction to GMP Compliance for New Drugs Launching a new drug in Europe involves navigating a complex regulatory framework, with Good Manufacturing Practices (GMP) being a critical requirement. The European Medicines…

GMP in Europe (EMA, MHRA)